What is the clinically relevant endpoint for cancer prevention trials?
Markman
Maurie
M
D015415:Biomarkers / Q000378:metabolism; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000517:prevention & control / Q000628:therapy; D012107:Research Design
D015415:Biomarkers